The price of this share is at 28,96$, In this post we are going to talk about the listed company Supernus Pharmaceuticals Inc, its leaders are Frank Mottola (Senior VP-Quality, GMP Operations & IT), Jack A. Khattar (President, CEO, Secretary & Director), Jonathan Rubin (Chief Medical Officer & Senior Vice President), Padmanabh P. Bhatt (Chief Scientific Officer & Senior Vice President), Timothy C. Dec (Chief Financial Officer & Senior Vice President), they lead it to work in Biotechnology: Pharmaceutical Preparations especially in the North America region.
The closing price of the stock yesterday was desconocido$.
With an intraday difference of 29,42$ moving between 28,27$ and 30,57$, it is a notable difference that allows quick purchases and sales.
The company has an annual revenue of desconocido.
The last registered opening is of desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].
Buscar
